RHUMBLINE ADVISERS - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 96 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$2,016,000
+118.2%
53,509
-1.5%
0.00%
+200.0%
Q4 2020$924,000
+342.1%
54,312
+22.2%
0.00%
Q3 2020$209,000
-33.4%
44,459
-13.7%
0.00%
-100.0%
Q2 2020$314,000
+132.6%
51,530
-13.3%
0.00%
Q1 2020$135,000
-48.9%
59,405
+3.4%
0.00%
Q4 2019$264,000
+18.9%
57,433
+0.4%
0.00%
Q3 2019$222,000
-30.0%
57,190
+8.9%
0.00%
-100.0%
Q2 2019$317,000
-51.1%
52,533
+8.7%
0.00%0.0%
Q1 2019$648,000
+43.4%
48,344
-0.6%
0.00%0.0%
Q4 2018$452,000
-5.0%
48,640
+42.1%
0.00%0.0%
Q3 2018$476,000
-10.9%
34,228
+1.3%
0.00%0.0%
Q2 2018$534,000
-4.0%
33,782
+4.4%
0.00%0.0%
Q1 2018$556,000
-13.9%
32,367
+9.7%
0.00%0.0%
Q4 2017$646,000
-54.4%
29,492
-14.9%
0.00%
-66.7%
Q3 2017$1,418,000
+37.4%
34,672
+1.1%
0.00%
+50.0%
Q2 2017$1,032,000
-15.5%
34,282
+1.4%
0.00%
-33.3%
Q1 2017$1,222,000
-25.7%
33,798
+3.0%
0.00%
-25.0%
Q4 2016$1,645,000
-3.5%
32,828
+1.0%
0.00%
-20.0%
Q3 2016$1,705,000
+30.6%
32,490
+2.9%
0.01%
+25.0%
Q2 2016$1,306,000
+40.4%
31,575
+37.9%
0.00%
+33.3%
Q1 2016$930,000
+2.5%
22,899
+4.8%
0.00%0.0%
Q4 2015$907,000
+206.4%
21,859
+13.5%
0.00%
+200.0%
Q3 2015$296,000
-35.8%
19,259
+3.9%
0.00%0.0%
Q2 2015$461,000
+8.2%
18,540
-0.6%
0.00%0.0%
Q1 2015$426,000
+12.7%
18,655
+33.2%
0.00%0.0%
Q4 2014$378,000
+152.0%
14,005
+9.2%
0.00%
Q3 2014$150,000
-24.6%
12,8200.0%0.00%
-100.0%
Q2 2014$199,00012,8200.00%
Other shareholders

There were no reported owners of FIVE PRIME THERAPEUTICS INC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of FIVE PRIME THERAPEUTICS INC shareholders